House Appropriators Tip-Toe Into Biologics Transition Controversy

 
• By Derrick Gingery
  
Capitol House
The US FDA's FY 2020 appropriations bill now moves to the full House of Representatives for consideration. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership